These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1831 related items for PubMed ID: 18540493

  • 1. Managing hypertension using combination therapy.
    Frank J.
    Am Fam Physician; 2008 May 01; 77(9):1279-86. PubMed ID: 18540493
    [Abstract] [Full Text] [Related]

  • 2. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA, McAlister FA, Campbell NR, Feldman RD, Rabkin S, Mahon J, Lewanczuk R, Zarnke KB, Hemmelgarn B, Lebel M, Levine M, Herbert C, Canadian Hypertension Education Program.
    Can J Cardiol; 2004 Jan 01; 20(1):41-54. PubMed ID: 14968142
    [Abstract] [Full Text] [Related]

  • 3. Current recommendations for the treatment of hypertension: are they still valid?
    Moser M.
    J Hypertens Suppl; 2002 Feb 01; 20(1):S3-10. PubMed ID: 11996197
    [Abstract] [Full Text] [Related]

  • 4. [Recent intervention studies with antihypertensive drugs and their influence on guidelines].
    Rahn KH.
    Med Klin (Munich); 2003 Dec 15; 98(12):771-5. PubMed ID: 14685679
    [Abstract] [Full Text] [Related]

  • 5. The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.
    Khan NA, McAlister FA, Lewanczuk RZ, Touyz RM, Padwal R, Rabkin SW, Leiter LA, Lebel M, Herbert C, Schiffrin EL, Herman RJ, Hamet P, Fodor G, Carruthers G, Culleton B, DeChamplain J, Pylypchuk G, Logan AG, Gledhill N, Petrella R, Campbell NR, Arnold M, Moe G, Hill MD, Jones C, Larochelle P, Ogilvie RI, Tobe S, Houlden R, Burgess E, Feldman RD, Canadian Hypertension Education Program.
    Can J Cardiol; 2005 Jun 15; 21(8):657-72. PubMed ID: 16003449
    [Abstract] [Full Text] [Related]

  • 6. Treatment of hypertension in chronic kidney disease.
    Toto RD.
    Semin Nephrol; 2005 Nov 15; 25(6):435-9. PubMed ID: 16298269
    [Abstract] [Full Text] [Related]

  • 7. RAS inhibition in hypertension.
    Ibrahim MM.
    J Hum Hypertens; 2006 Feb 15; 20(2):101-8. PubMed ID: 16397519
    [Abstract] [Full Text] [Related]

  • 8. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.
    Kuti EL, Baker WL, White CM.
    Curr Med Res Opin; 2007 Jun 15; 23(6):1239-44. PubMed ID: 17559720
    [Abstract] [Full Text] [Related]

  • 9. [Medical treatment of hypertension--what treatment for what patients?].
    Zidek W, Tepel M, van der Giet M.
    MMW Fortschr Med; 2004 May 27; 146(22):31-4. PubMed ID: 15373106
    [Abstract] [Full Text] [Related]

  • 10. Long-term safety of antihypertensive therapy.
    Grossman E, Messerli FH.
    Prog Cardiovasc Dis; 2006 May 27; 49(1):16-25. PubMed ID: 16867847
    [Abstract] [Full Text] [Related]

  • 11. Antihypertensive therapy in the presence of proteinuria.
    Sarafidis PA, Khosla N, Bakris GL.
    Am J Kidney Dis; 2007 Jan 27; 49(1):12-26. PubMed ID: 17185142
    [Abstract] [Full Text] [Related]

  • 12. The case for beta-blockers as first-line antihypertensive therapy.
    Cruickshank JM.
    J Hypertens Suppl; 1992 Jun 27; 10(3):S21-7. PubMed ID: 1353111
    [Abstract] [Full Text] [Related]

  • 13. [Are all antihypertensive drugs renoprotective?].
    Wolf S, Risler T.
    Herz; 2004 May 27; 29(3):248-54. PubMed ID: 15167950
    [Abstract] [Full Text] [Related]

  • 14. Pharmacologic management of hypertension in patients with diabetes.
    Whalen KL, Stewart RD.
    Am Fam Physician; 2008 Dec 01; 78(11):1277-82. PubMed ID: 19069021
    [Abstract] [Full Text] [Related]

  • 15. The need for evidence in hypertension management: historical perspective.
    Moawad MA.
    Ann Saudi Med; 2005 Dec 01; 25(5):367-74. PubMed ID: 16270757
    [Abstract] [Full Text] [Related]

  • 16. Combination therapy with ACE inhibitors/angiotensin II receptor antagonists and diuretics in hypertension.
    Waeber B.
    Expert Rev Cardiovasc Ther; 2003 May 01; 1(1):43-50. PubMed ID: 15030296
    [Abstract] [Full Text] [Related]

  • 17. Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function.
    Morimoto S, Maki K, Aota Y, Sakuma T, Iwasaka T.
    Hypertens Res; 2008 Aug 01; 31(8):1603-10. PubMed ID: 18971536
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of recent fixed-dose combination therapies in the management of hypertension.
    Khanna A, Lefkowitz L, White WB.
    Curr Opin Nephrol Hypertens; 2008 Sep 01; 17(5):477-83. PubMed ID: 18695388
    [Abstract] [Full Text] [Related]

  • 19. [Combination therapy in primary hypertension].
    Halawa B.
    Pol Merkur Lekarski; 1998 Jan 01; 4(19):35-8. PubMed ID: 9553408
    [Abstract] [Full Text] [Related]

  • 20. Management of hypertension. What is the role of beta blockers?
    Gifford RW.
    Postgrad Med; 1988 Feb 29; Spec No():46-9. PubMed ID: 2894661
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 92.